Comparative Effects of Irbesartan Versus Amlodipine on Left Ventricular Mass Index in Hypertensive Patients with Left Ventricular Hypertrophy
Authors:
- Carlo GaudioCGCarlo Gaudio
- Fabio Massimo FerriFFFabio Massimo Ferri
- Marco GiovanniniMGMarco Giovannini
- Giuseppe PannaraleGPGiuseppe Pannarale
- Paolo Emilio PudduPaolo Emilio Puddu
- Alessandro VittoreAVAlessandro Vittore
- Maria Stella FeraMFMaria Stella Fera
- Carmine Dario VizzaCVCarmine Dario Vizza
- Francesco FedeleFFFrancesco Fedele
- 1 November 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 42 (5) , 622-628
Abstract
The aim of this study was to comparatively assess the effects of irbesartan and amlodipine monotherapies on left ventricular mass index (LVMI) in patients with mild to moderate untreated hypertension and echocardiographically determined left ventricular hypertrophy (LVH). Sixty hypertensive patients (35 men, 25 women; mean age, 52.8 years ± 12.6) with diastolic blood pressure (BP) ≥ 100 mm Hg were randomized to irbesartan 150 mg once daily or amlodipine 5 mg once daily for a 4-week titration period. Dosage of both drugs was increased to irbesartan 300 mg once daily or amlodipine 10 mg once daily in case of sitting diastolic BP still >90 mm Hg after the first 2 weeks of treatment. Dosage doubling was necessary in more than 50% of patients in both treatment groups. After the titration period, only the responders (sitting diastolic BP ≤ 90 mm Hg) entered a 5-month maintenance period. After 3 months, echocardiographically estimated LVMI decreased by 23.2% in the irbesartan-treated patients and 11.4% in the amlodipine-treated patients, with an adjusted mean difference of 11.8% in favor of irbesartan (P < 0.0001). After 6 months, it decreased by 24.7% in the irbesartan-treated patients and 13.0% in the amlodipine-treated patients, with an adjusted mean difference of 11.6% in favor of irbesartan (P < 0.0001).Keywords
This publication has 45 references indexed in Scilit:
- Left Ventricular Hypertrophy in HypertensionNew England Journal of Medicine, 1999
- Meta-analysis. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)Nephrology Dialysis Transplantation, 1998
- Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential HypertensionCirculation, 1998
- Association of change in left ventricular mass with prognosis during long-term antihypertensive treatmentJournal Of Hypertension, 1995
- Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.Circulation, 1994
- Reversal of Left Ventricular Hypertrophy in Hypertensive PatientsAmerican Journal of Hypertension, 1992
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular HypertrophyNew England Journal of Medicine, 1987
- Left Ventricular Hypertrophy and Risk of Cardiac FailureJournal of Cardiovascular Pharmacology, 1987
- Cardiac hypertrophy: Useful adaptation or pathologic process?The American Journal of Medicine, 1980